First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
4 hedge funds and large institutions have $628K invested in First Trust Nasdaq Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$26K |
| 2 |
IA
2
IFP Advisors
Tampa,
Florida
|
$4K |
Top Sellers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$587K |
| 2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$11K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $587K | 29,579 | -19,889 | -40% |
|
|
2
UBS Group
Zurich,
Switzerland
| $26K | 1,300 | +1,300 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | 557 | -551 | -50% |
|
|
IA
4
IFP Advisors
Tampa,
Florida
| $4K | 200 | +200 | New |
|